We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
Cap. Flow
-$880M
Cap. Flow %
-3.82%
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$63.2M
2
EXP icon
Eagle Materials
EXP
+$56.2M
3
ITRI icon
Itron
ITRI
+$54.4M
4
AAPL icon
Apple
AAPL
+$52.6M
5
ENPH icon
Enphase Energy
ENPH
+$40.6M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$82.8M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
MSFT icon
Microsoft
MSFT
+$62.6M
4
ADBE icon
Adobe
ADBE
+$62.2M
5
JBL icon
Jabil
JBL
+$41M

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 19.28%
3 Financials 10.14%
4 Communication Services 9.05%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MC icon
1026
Moelis & Co
MC
$5.21B
$668K ﹤0.01%
11,751
SFBS
1027
ServisFirst Bancshares
SFBS
$5B
$665K ﹤0.01%
10,523
ACAD icon
1028
Acadia Pharmaceuticals
ACAD
$4.89B
$664K ﹤0.01%
40,833
AZTA icon
1029
Azenta
AZTA
$1.49B
$662K ﹤0.01%
12,581
ROG icon
1030
Rogers Corp
ROG
$2.46B
$660K ﹤0.01%
5,472
+1,400
+34% +$164K
EPR icon
1031
EPR Properties
EPR
$4.73B
$659K ﹤0.01%
15,700
+2,400
+18% +$98.7K
PAG icon
1032
Penske Automotive Group
PAG
$14.4B
$658K ﹤0.01%
4,416
NVST icon
1033
Envista
NVST
$4.51B
$657K ﹤0.01%
39,500
CTRE icon
1034
CareTrust REIT
CTRE
$9.18B
$654K ﹤0.01%
26,046
+8,700
+50% +$215K
RYTM icon
1035
Rhythm Pharmaceuticals
RYTM
$7.99B
$654K ﹤0.01%
15,921
ABM icon
1036
ABM Industries
ABM
$2.82B
$653K ﹤0.01%
12,909
KLIC icon
1037
Kulicke & Soffa
KLIC
$5.01B
$653K ﹤0.01%
13,274
KFY icon
1038
Korn Ferry
KFY
$4.36B
$651K ﹤0.01%
9,702
BIRK icon
1039
Birkenstock
BIRK
$7.54B
$647K ﹤0.01%
+11,900
New +$590K
JJSF icon
1040
J&J Snack Foods
JJSF
$1.7B
$646K ﹤0.01%
3,979
TSN icon
1041
Tyson Foods
TSN
$19.8B
$644K ﹤0.01%
11,262
-77,458
-87% -$4.53M
WU icon
1042
Western Union
WU
$2.34B
$643K ﹤0.01%
52,600
FOXF icon
1043
Fox Factory Holding Corp
FOXF
$886M
$642K ﹤0.01%
13,330
+5,300
+66% +$240K
NSP icon
1044
Insperity
NSP
$2.05B
$642K ﹤0.01%
7,044
JBTM
1045
JBT Marel
JBTM
$6.1B
$641K ﹤0.01%
6,751
PEGA icon
1046
Pegasystems
PEGA
$5.51B
$638K ﹤0.01%
21,088
+3,200
+18% +$95.9K
DIOD icon
1047
Diodes
DIOD
$4.48B
$634K ﹤0.01%
8,809
+1,300
+17% +$93.2K
IDCC icon
1048
InterDigital
IDCC
$8.88B
$633K ﹤0.01%
5,430
BGC icon
1049
BGC Group
BGC
$5.2B
$632K ﹤0.01%
76,178
SITM icon
1050
SiTime
SITM
$20.7B
$632K ﹤0.01%
5,084
+1,300
+34% +$139K

Similar funds

Handelsbanken Fonder's Q2 2024 Portfolio in Review

As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.

  • Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
  • Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
  • Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
  • Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
  • Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
  • Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.